ruxolitinib

Ruxolitinib Phosphate (1092939-17-7) Ruxolitinib is an anti-tumor pharmaceutical agent indicated for the treatment of myeloproliferative neoplasm-associated myelofibrosis, polycythemia vera, and other myeloproliferative neoplasms, as well as refractory cancers. Product Specifications Product Name: Ruxolitinib Phosphate CAS No.: 1092939-17-7 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C17 H21 N6 O4 P Molecular Weight: 404.36 Shelf Life: 2 Years

4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine (941685-26-3) 4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine is a key intermediate compound used in the design and synthesis of ruxolitinib, an important pharmaceutical agent. Product Specifications Product Name: 4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 941685-26-3 Assay: 98% End Use: Ruxolitinib Molecular Formula: C12H18ClN3OSi

3-Cyclopentylacrylonitrile (591769-05-0) 3-Cyclopentylacrylonitrile and its derivatives serve as key intermediates in the synthesis of pharmaceutical compounds including ruxolitinib intermediates and trasitinib phosphate. Product Specifications Product Name: 3-cyclopentylacrylonitrile CAS No.: 591769-05-0 Assay: 98% Molecular Formula: C9H12 Molecular Weight: 120.19 Shelf Life: 2 Years Package: 25kg/drum Product Images